Clinical Trials Logo

Filter by:
NCT ID: NCT02603900 Withdrawn - Acute Pain Clinical Trials

Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty

Start date: October 2015
Phase: Phase 4
Study type: Interventional

The study is a prospective randomized controlled trial comparing local infiltration of analgesia in the knee joint and adductor canal catheters for postoperative analgesia following a primary Total Knee Arthroplasty (TKA).

NCT ID: NCT02603458 Withdrawn - Schizophrenia Clinical Trials

NRX-1074 in Early Course Schizophrenia

Start date: n/a
Phase: Phase 2
Study type: Interventional

This study seeks to examine the effectiveness of NRX-1074 in the treatment of negative symptoms and cognition in schizophrenia compared to other agents at the glycine site which have demonstrated inconsistent results for negative symptoms. In addition to testing efficacy, we will examine the time course of response of symptoms as well as any effects on memory consolidation.

NCT ID: NCT02603068 Withdrawn - Clinical trials for Pulmonary Hypertension

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Start date: February 2016
Phase: Phase 2
Study type: Interventional

This multicenter, randomized, open-label study will assess the safety and efficacy of oral treprostinil in subjects diagnosed with pulmonary hypertension associated with pulmonary fibrosis.

NCT ID: NCT02602665 Withdrawn - Clinical trials for Vascular Access Complication

Central Line Placement-EVALUATION OF LINE DEPTH AS A FACTOR IN NEED FOR LINE REPLACEMENT SECONDARY TO MALPOSITION

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

This is a single center, randomized, controlled trial in which tunneled central line catheters will be placed in two distinct, select positions. The catheter tip position will then be followed up prospectively after placement to determine whether there is any malpositioning of the tip and if one placement is better than the other.

NCT ID: NCT02600572 Withdrawn - Therapy, Exercise Clinical Trials

Changes in Attention Level Due to Isometric Exercises and Level Three Progression Eccentric Movements

Start date: January 2016
Phase: N/A
Study type: Interventional

Determine the changes in attention level due to isometric exercises and level three progression eccentric movements. The attention level will be measured using a mental speed test (how quickly a subject can process information and make decisions based upon that information). Another outcome measure will be the ability of the subject to maintain balance

NCT ID: NCT02599727 Withdrawn - Exercise, Isometric Clinical Trials

Effects of Isometric Exercises on Balance, Heart Rate, Pulse Ox and Blood Pressure

Start date: November 2015
Phase: N/A
Study type: Interventional

Determine the effects repeated isometric exercises have on balance, blood pressure, heart rate and pulse ox. Another outcome measure will be a mental speed test (how quickly a subject can process information and make decisions based upon that information).

NCT ID: NCT02598674 Withdrawn - Hypertension Clinical Trials

Severe Sepsis in Children - IMPRESS-C

IMPRESS-C
Start date: October 2019
Phase:
Study type: Observational

Sepsis is the most common cause of childhood death worldwide. Millions of children survive, but are left with impaired health. Sepsis-related Acute Kidney Injury (sAKI) is increasingly recognized as a significant factor associated with long-term mortality among different patient populations. Renal dysfunction and subsequent chronic kidney disease is implicated in the development of hypertension and cardiovascular disease. The investigators overall hypothesis is that, in the pediatric population, sepsis-related AKI will have unrecognized, long-term consequences with regard to kidney function, endothelial function, blood pressure control, and overall health.

NCT ID: NCT02598479 Withdrawn - Cancer Clinical Trials

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

IPTLDAZCAM
Start date: November 2015
Phase:
Study type: Observational

The IPTLD QoL Broad Study.

NCT ID: NCT02597894 Withdrawn - Clinical trials for Stage III Prostate Adenocarcinoma

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

This pilot clinical trial studies targeted biopsies in determining response in patients with prostate cancer undergoing high-dose-rate brachytherapy (a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor). Studying tumor tissue obtained before and after treatment may help doctors understand changes in a pathway that looks at how deoxyribonucleic acid (DNA) is repaired after it is damaged and to see if there are differences in the prostate tissue prior to and after starting androgen deprivation therapy.

NCT ID: NCT02597660 Withdrawn - Tendinopathy Clinical Trials

A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy

Start date: May 1, 2020
Phase: Phase 2
Study type: Interventional

Patellar tendinopathy is one of the most frequent causes of non-traumatic knee pain and reduced function in patients. Standard treatment options for patellar tendinopathies include non-steroidal anti-inflammatory drugs, corticosteroids, cryotherapy, manual therapy, eccentric exercises, and ultrasound. Unfortunately many patients fail to respond to these therapies and return to normal activity levels, and recurrence rates for those who do respond are unacceptably high. Many patients who fail to respond display persistent degenerative changes on imaging studies suggesting a failure to regenerate the pathological tissue. Developing new therapies that can directly promote the synthesis of new, healthy extracellular matrix tissue could therefore address an important therapeutic need and make a substantial improvement in our ability to effectively treat patellar tendinopathy and reduce recurrence rates. Somatropin (human growth hormone of recombinant DNA origin) has been shown to increase protein synthesis and matrix production when delivered directly into the tendon. This study will evaluate the ability of somatropin to improve clinical outcomes and tissue quality in patients with chronic tendinopathy.